Safety and Efficacy Evaluation of the Mosaic Ultra Device

Inclusion Criteria: * Non-smoking, Male or Female * Age 18 - 60 years old * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated. * Participants who are willing and able to comply with all study participation requirements including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study. * OPTIONAL - Participants who are willing to undergo biopsies. Exclusion Criteria: * Previous surgical or cosmetic procedure to the target area in the last 6 to 12 months that could interfere with the treatment procedure * A study participant must not be pregnant or have been pregnant in the last 3 months * A recent history of smoking (6 months) * Presence of an active skin disease or condition that may affect wound healing (ie. diabetes myelitis; connective tissue disease; radiation therapy; or chemotherapy) * Seizure disorder caused by bright light * A history of thrombophlebitis * A history of acute infections * A history of heart failure * Cancer, malignant disease, skin pathology, condition, or allergic reactions that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during, or after treatments * Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, vitamin E, or anti-inflammatories within 2 weeks prior to treatment * Intolerance or allergy to medications that could be prescribed before or after the procedure (eg, antibiotics, anesthesia) * A history of keloids * A history or evidence of poor wound healing * A history of coagulative disorder or current use of anticoagulant drugs within 2 weeks of study participation * Use of steroids within 2 weeks of study treatments * Patients with implanted pacemaker or defibrillator, or metal pins, or prosthetic joints within 4 cm of treatment area * History of psychoneurosis and/or a history of alcohol or drug abuse